Study: Latinas at Higher Risk for Metablic Syndrome
High incidence of heart disease among Latinas is directly related to a higher risk for metabolic syndrome, according to a study by Dr. Fatima Rodriguez of Brigham and Women’s Hospital in Boston, Voxxi reports.
Metabolic syndrome is a combination of factors—high blood pressure, increased levels of blood sugar, excessive body fat, and abnormal cholesterol levels—that lead to an increased risk of heart disease, stroke and diabetes.
Rodriguez’ study, published in Family Practice News, collected information from the health screenings of 18,000 women and complete medical histories for 7,000 women.
Her findings, according to the report, include:
Researchers found an overall prevalence of metabolic syndrome for 35 percent of evaluated women; however, Rodriguez states “there was a disproportionate burden for Hispanic womenand black women.”
Forty percent of Hispanic women were classified as having metabolic syndrome compared to 39 percent of blacks, 31 percent of whites, and 29 percent of women who identified themselves as “other.”
The research also revealed most of the metabolic syndrome seen in Latinas was related to abnormal lipid levels, most notably among the youngest participants.
“Many of these women have high triglyceride levels and low HDL levels … and this disparity was most pronounced in young women,” Rodriguez said.
Read more here.
- Study: Latinas Have Severe Time Delay between Abnormal Mammogram, Confirmation of Breast Cancer
- Feb. 1 is ‘National Wear Red Day’ for Heart Disease Awareness
- Video: A Latina’s Touching ‘Heart Story’
- ‘Tu Corazon’ Summit to Examine Heart Disease’s Influence in Latinos
- Heart Disease Risk Higher among ‘Acculturated’ Latinos; Risk Factors Vary by Latino Background
- Obesity: Mexico Starts War Against Sugary Drinks, Fatty Foods
- Despite Progress, Heart Disease Still a Top Killer of Latinas, Other Women
- For U.S. Hispanics, Cancer Top Killer, Not Heart
- Video: How You Spend Your Free Time Can Lower Risk for Heart Disease
- Latinas Interested in Genetic Testing for Breast Cancer Risk, But Barriers Persist